<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04241107</url>
  </required_header>
  <id_info>
    <org_study_id>Uterine niche repair</org_study_id>
    <nct_id>NCT04241107</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Transvaginal Approaches in Repair of Uterine Niche: A Randomized Controlled Trial</brief_title>
  <acronym>isthmocele</acronym>
  <official_title>Laparoscopic Versus Transvaginal Approaches in Repair of Uterine Niche: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of uterine niche ranges from clinical management with expectant or
      pharmacological treatment, surgical treatment. Approaches for repair include Laparotomy,
      laparoscopy , hysteroscopy , vaginal. The decision to treat takes into consideration the size
      of the defect, presence of symptoms, secondary infertility and plans of pregnancy.

      All of the approaches have its merits and debates. There is ongoing debate regarding the best
      surgical approach to managing this condition. To date no randomized controlled trials have
      been published to settle this debate.

      Our study aim is to to evaluate which surgical approach is a preferable option, this study
      will be conducted to compare the Laparoscopic and transvaginal approaches in several regards,
      including, operation time, blood loss, perioperative complications, hospital stay length,
      postoperative increase in residual myometrial thickness during follow-up , clinical
      efficacy(percentage of patients who subject improvement of symptoms)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical efficacy</measure>
    <time_frame>3 month postoperative</time_frame>
    <description>Number of patients who subject clinical improvement of pre-operative symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative increase in residual myometrial thickness</measure>
    <time_frame>3 month postoperative</time_frame>
    <description>difference between pre-operative &amp; post-operative residual myometrial thickness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of operation</measure>
    <time_frame>baseline( During operation)</time_frame>
    <description>duration from anesthesia till end of operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>baseline( During operation)</time_frame>
    <description>estimated blood loss during operation(towels , suction container)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative complication</measure>
    <time_frame>baseline( During operation)</time_frame>
    <description>complication during the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Uterine Niche</condition>
  <arm_group>
    <arm_group_label>Laparoscopic approach group(A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Uterine niche will be repaired through Laparoscopic approach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transvaginal approach group(B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Uterine niche will be repaired through Transvaginal approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic repair of Uterine niche</intervention_name>
    <description>Repair of uterine niche through Laparoscopic approach.</description>
    <arm_group_label>Laparoscopic approach group(A)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvaginal repair of Uterine niche</intervention_name>
    <description>Repair of uterine niche through Transvaginal approach.</description>
    <arm_group_label>Transvaginal approach group(B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients who have uterine niche (defined as myometrial discontinuity or a hypoechoic
        triangle in the myometrium of the anterior uterine wall at the site of hysterotomy
        presented in transvaginal ultrasound or sonohysterography examination in non-pregnant
        women) ,with one or more previous caesarean section Who are:

          1. Symptomatic i.e patients having one or more of the following symptoms:

               1. Postmenstrual spotting (defined as more than 2 days of brownish discharge at the
                  end of menstruation with a total length of menstruation (including spotting) of
                  more than 7 days, or intermenstrual bleeding which starts within 5 days after the
                  end of menstruation. [15]),

               2. Secondary Dysmenorrhea( defined as the pain or discomfort associated with
                  menstruation)

               3. deep dyspareunia(deep genital pain associated with sexual intercourse)

               4. Chronic pelvic pain can be defined as intermittent or constant pain in the lower
                  abdomen or pelvis of a woman of at least 6 months in duration, not occurring
                  exclusively with menstruation or intercourse and not associated with pregnancy.

               5. secondary infertility (defined by the World Health Organization as, ―when a woman
                  is unable to bear a child, either due to the inability to become pregnant or the
                  inability to carry a pregnancy to a live birth following either a previous
                  pregnancy or previous ability to carry a pregnancy to a live birth.)

          2. Asymptomatic patients with one of the followings:

             the residual myometrial thickness over the niche less than 3 mm previous history of
             Cesarean Section scar ectopic pregnancy (not managed by resection and repair)

          3. who accept to participate the study.

        Exclusion Criteria:

          1. Asymptomatic patients with residual myometrial thickness more than 3 mm.

          2. No previous Cesarean section.

          3. If the patients symptoms presented before Cesarean section.

          4. Presence of other pathology that explain patient symptoms

               1. sub mucous fibroid

               2. cervical-Endometrial carcinoma

               3. Endometrial hyperplasia

               4. Coagulation defect.

          5. Presence of pathology that necessitate laparotomy.

          6. Patient who refuse to participate the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Abdel-Aleem, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahmoud zakhera, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Abo El Fadle, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdulrahman Muhammad Rageh, M.Sc</last_name>
    <phone>02 01005056259</phone>
    <email>Abdulrahmanrageh.26.9@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abdulrahman Muhammad Rageh</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdulrahman Muhammad Rageh, MSc</last_name>
      <phone>+201005056259</phone>
      <email>Abdulrahmanrageh.26.9@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.researchgate.net/publication/273145514_Various_Types_of_Niche_Imaging_by_Sonohysterography_A_Pictorial_Review</url>
    <description>Various Types of Niche Imaging by Sonohysterography</description>
  </link>
  <reference>
    <citation>Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM; WHO Working Group on Caesarean Section. WHO Statement on Caesarean Section Rates. BJOG. 2016 Apr;123(5):667-70. doi: 10.1111/1471-0528.13526. Epub 2015 Jul 22.</citation>
    <PMID>26681211</PMID>
  </reference>
  <reference>
    <citation>Elnakib S, Abdel-Tawab N, Orbay D, Hassanein N. Medical and non-medical reasons for cesarean section delivery in Egypt: a hospital-based retrospective study. BMC Pregnancy Childbirth. 2019 Nov 8;19(1):411. doi: 10.1186/s12884-019-2558-2.</citation>
    <PMID>31703638</PMID>
  </reference>
  <reference>
    <citation>Bij de Vaate AJ, van der Voet LF, Naji O, Witmer M, Veersema S, Brölmann HA, Bourne T, Huirne JA. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet Gynecol. 2014 Apr;43(4):372-82. doi: 10.1002/uog.13199. Review.</citation>
    <PMID>23996650</PMID>
  </reference>
  <reference>
    <citation>Tulandi T, Cohen A. Emerging Manifestations of Cesarean Scar Defect in Reproductive-aged Women. J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):893-902. doi: 10.1016/j.jmig.2016.06.020. Epub 2016 Jul 5. Review.</citation>
    <PMID>27393285</PMID>
  </reference>
  <reference>
    <citation>Vervoort AJ, Uittenbogaard LB, Hehenkamp WJ, Brölmann HA, Mol BW, Huirne JA. Why do niches develop in Caesarean uterine scars? Hypotheses on the aetiology of niche development. Hum Reprod. 2015 Dec;30(12):2695-702. doi: 10.1093/humrep/dev240. Epub 2015 Sep 25.</citation>
    <PMID>26409016</PMID>
  </reference>
  <reference>
    <citation>Sipahi S, Sasaki K, Miller CE. The minimally invasive approach to the symptomatic isthmocele - what does the literature say? A step-by-step primer on laparoscopic isthmocele - excision and repair. Curr Opin Obstet Gynecol. 2017 Aug;29(4):257-265. doi: 10.1097/GCO.0000000000000380. Review.</citation>
    <PMID>28598911</PMID>
  </reference>
  <reference>
    <citation>van der Voet LF, Bij de Vaate AM, Veersema S, Brölmann HA, Huirne JA. Long-term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. BJOG. 2014 Jan;121(2):236-44. doi: 10.1111/1471-0528.12542.</citation>
    <PMID>24373597</PMID>
  </reference>
  <reference>
    <citation>Tower AM, Frishman GN. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):562-72. doi: 10.1016/j.jmig.2013.03.008. Epub 2013 May 14. Review.</citation>
    <PMID>23680518</PMID>
  </reference>
  <reference>
    <citation>Marotta ML, Donnez J, Squifflet J, Jadoul P, Darii N, Donnez O. Laparoscopic repair of post-cesarean section uterine scar defects diagnosed in nonpregnant women. J Minim Invasive Gynecol. 2013 May-Jun;20(3):386-91. doi: 10.1016/j.jmig.2012.12.006. Epub 2013 Jan 26.</citation>
    <PMID>23357466</PMID>
  </reference>
  <reference>
    <citation>Abacjew-Chmylko A, Wydra DG, Olszewska H. Hysteroscopy in the treatment of uterine cesarean section scar diverticulum: A systematic review. Adv Med Sci. 2017 Sep;62(2):230-239. doi: 10.1016/j.advms.2017.01.004. Epub 2017 May 10. Review.</citation>
    <PMID>28500899</PMID>
  </reference>
  <reference>
    <citation>Ludwin A, Martins WP, Ludwin I. Evaluation of uterine niche by three-dimensional sonohysterography and volumetric quantification: techniques and scoring classification system. Ultrasound Obstet Gynecol. 2019 Jan;53(1):139-143. doi: 10.1002/uog.19181.</citation>
    <PMID>30039641</PMID>
  </reference>
  <reference>
    <citation>Zhang X, Yang M, Wang Q, Chen J, Ding J, Hua K. Prospective evaluation of five methods used to treat cesarean scar defects. Int J Gynaecol Obstet. 2016 Sep;134(3):336-9. doi: 10.1016/j.ijgo.2016.04.011. Epub 2016 Jun 30.</citation>
    <PMID>27473332</PMID>
  </reference>
  <reference>
    <citation>Donnez O, Jadoul P, Squifflet J, Donnez J. Laparoscopic repair of wide and deep uterine scar dehiscence after cesarean section. Fertil Steril. 2008 Apr;89(4):974-80. Epub 2007 Jul 10.</citation>
    <PMID>17624346</PMID>
  </reference>
  <reference>
    <citation>Bij de Vaate AJ, Brölmann HA, van der Voet LF, van der Slikke JW, Veersema S, Huirne JA. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstet Gynecol. 2011 Jan;37(1):93-9. doi: 10.1002/uog.8864.</citation>
    <PMID>21031351</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>February 3, 2020</last_update_submitted>
  <last_update_submitted_qc>February 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Abdulrahman Muhammad Rageh</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <keyword>Cesarean Scar defect</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

